Abstract
Purpose
End-stage renal disease (ESRD) is a well-recognized risk factor for the development of sudden cardiac arrest (SCA). There is limited data on baseline characteristics and outcomes after an in-hospital SCA event in ESRD patients.
Methods
For the purpose of this study, data were obtained from the National Inpatient Sample from January 2007 to December 2017. In-hospital SCA was identified using the International Classification of Disease, 9th Revision, Clinical Modification and International Classification of Disease, 10th Revision, Clinical Modification codes of 99.60, 99.63, and 5A12012. ESRD patients were subsequently identified using codes of 585.6 and N18.6. Baseline characteristics and outcomes were compared among ESRD and non-ESRD patients in crude and propensity score (PS)–matched cohorts. Predictors of mortality in ESRD patients after an in-hospital SCA event were analyzed using a multivariate logistic regression model.
Results
A total of 1,412,985 patients sustained in-hospital SCA during our study period. ESRD patients with in-hospital SCA were younger and had a higher burden of key co-morbidities. Mortality was similar in ESRD and non-ESRD patients in PS-matched cohort (70.4% vs. 70.7%, p = 0.45) with an overall downward trend over our study years. Advanced age, Black race, and key co-morbidities independently predicted increased mortality while prior implantable defibrillator was associated with decreased mortality in ESRD patients after an in-hospital SCA event.
Conclusions
In the context of in-hospital SCA, mortality is similar in ESRD and non-ESRD patients in adjusted analysis. Adequate risk factor modification could further mitigate the risk of in-hospital SCA among ESRD patients.
Similar content being viewed by others
Data availability
The data that support the finding of this study are available from the corresponding author (MBM) upon reasonable request.
References
Saran R, Li Y, Robinson B, Ayanian J, Balkrishnan R, Bragg-Gresham J, Chen JT, Cope E, Gipson D, He K, Herman W, Heung M, Hirth RA, Jacobsen SS, Kalantar-Zadeh K, Kovesdy CP, Leichtman AB, Lu Y, Molnar MZ, Morgenstern H, Nallamothu B, O’Hare AM, Pisoni R, Plattner B, Port FK, Rao P, Rhee CM, Schaubel DE, Selewski DT, Shahinian V, Sim JJ, Song P, Streja E, Kurella Tamura M, Tentori F, Eggers PW, Agodoa LY, Abbott KC. US Renal Data System 2014 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2015;66(1 Suppl 1):Svii, S1–305
Alqahtani F, Almustafa A, Shah K, Akram Y, Abbasi D, Rattan R, et al. Sudden cardiac arrest in end-stage renal disease patients on dialysis: a nationwide study. Pacing Clin Electrophysiol. 2018;41:1467–75.
Haider AW, Larson MG, Benjamin EJ, Levy D. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol. 1998;32:1454–9.
Campese VM. Left ventricular function and chronic kidney disease: how soon does it start? Nephrol Dial Transplant. 2014;29:1989–91.
Genovesi S, Dossi C, Viganò MR, Galbiati E, Prolo F, Stella A. Electrolyte concentration during haemodialysis and QT interval prolongation in uraemic patients. Europace. 2008;6:771–7.
Karaboyas A, Zee J, Brunelli SM, Usvyat LA, Weiner DE, Maddux FW, et al. Dialysate potassium, serum potassium, mortality, and arrhythmia events in hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2017;69:266–77.
Mix TC, St Peter WL, Ebben J, Xue J, Pereira BJ, Kausz AT, et al. Hospitalization during advancing chronic kidney disease. Am J Kidney Dis. 2003;42:972–81.
Girotra S, Nallamothu BK, Spertus JA, Li Y, Krumholz HM. Chan PS; American Heart Association Get with the Guidelines–Resuscitation Investigators. Trends in survival after in-hospital cardiac arrest. N Engl J Med. 2012;367:1912–20.
Agency for Healthcare Research and Quality, Rockville, MD. http://www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed 25 March 2020
Kolte D, Khera S, Aronow WS, Palaniswamy C, Mujib M, Ahn C, et al. Regional variation in the incidence and outcomes of in-hospital cardiac arrest in the United States. Circulation. 2015;131:1415–25.
Morita Y, Haruna T, Haruna Y, Nakane E, Yamaji Y, Hayashi H, et al. Incidence, predictors, causes, and costs of 30-day readmission after in-hospital cardiopulmonary resuscitation in the United States. Resuscitation. 2019;134:19–25.
Khan MZ, Sulaiman S, Agrawal P, Osman M, Khan MU, Khan SU, et al. Targeted temperature management in cardiac arrest patients with a non-shockable rhythm: a national perspective. Am Heart J. 2020;225:129–37.
Andersen LW, Holmberg MJ, Berg KM, Donnino MW, Granfeldt A. In-hospital cardiac arrest: a review. JAMA. 2019;321:1200–10.
Saeed F, Adil MM, Malik AA, Schold JD, Holley JL. Outcomes of in-hospital cardiopulmonary resuscitation in maintenance dialysis patients. J Am Soc Nephrol. 2015;26:3093–101.
Starks MA, Wu J, Peterson ED, Stafford JA, Matsouaka RA, Boulware LE, et al. In-hospital cardiac arrest resuscitation practices and outcomes in maintenance dialysis patients. Clin J Am Soc Nephrol. 2020;15:219–27.
Field JM, Hazinski MF, Sayre MR, Chameides L, Schexnayder SM, Hemphill R, et al. Part 1: executive summary: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2010;122(18 suppl 3):S640–56.
Travers AH, Rea TD, Bobrow BJ, Edelson DP, Berg RA, Sayre MR, et al. Part 4: CPR overview: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2010;122(18 suppl 3):S676–84.
Shastri S, Tangri N, Tighiouart H, Beck GJ, Vlagopoulos P, Ornt D, et al. Predictors of sudden cardiac death: a competing risk approach in the hemodialysis study. Clin J Am Soc Nephrol. 2012;7:123–30.
Cice G, Ferrara L, D’Andrea A, D’Isa S, Di Benedetto A, Cittadini A, et al. Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial. J Am Coll Cardiol. 2003;41:1438–44.
Tangri N, Shastri S, Tighiouart H, Beck GJ, Cheung AK, Eknoyan G, et al. β-Blockers for prevention of sudden cardiac death in patients on hemodialysis: a propensity score analysis of the HEMO Study. Am J Kidney Dis. 2011;58:939–45.
Pun PH, Lehrich RW, Smith SR, Middleton JP. Predictors of survival after cardiac arrest in outpatient hemodialysis clinics. Clin J Am Soc Nephrol. 2007;2:491–500.
Munir MB, Alqahtani F, Aljohani S, Bhirud A, Modi S, Alkhouli M. Trends and predictors of implantable cardioverter defibrillator implantation after sudden cardiac arrest: insight from the national inpatient sample. Pacing Clin Electrophysiol. 2018;41:229–37.
Pun PH, Lehrich RW, Honeycutt EF, Herzog CA, Middleton JP. Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics. Kidney Int. 2011;79:218–27.
Pun PH, Horton JR, Middleton JP. Dialysate calcium concentration and the risk of sudden cardiac arrest in hemodialysis patients. Clin J Am Soc Nephrol. 2013;8:797–803.
Vlasschaert ME, Bejaimal SA, Hackam DG, Quinn R, Cuerden MS, Oliver MJ, et al. Validity of administrative database coding for kidney disease: a systematic review. Am J Kidney Dis. 2011;57:29–43.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The need for these entities was waived due to the de-identified nature of National Inpatient Sample database and its public availability.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
ESM 1
Supplementary Figure Predictors of mortality in non-end stage renal disease patients after in-hospital sudden cardiac arrest. (JPEG 129 kb)
Rights and permissions
About this article
Cite this article
Khan, M.Z., Syed, M., Agrawal, P. et al. Baseline characteristics and outcomes of end-stage renal disease patients after in-hospital sudden cardiac arrest: a national perspective. J Interv Card Electrophysiol 63, 503–512 (2022). https://doi.org/10.1007/s10840-021-00977-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-021-00977-1